The use and determinants of rate versus rhythm control for management of atrial fibrillation (AF) in community practice have not been thoroughly defined.
Background:
The use and determinants of rate versus rhythm control for management of atrial fibrillation (AF) in community practice have not been thoroughly defined.
Methods:
The ORBIT-AF registry enrolled patients with AF from a broad range of practice settings and collected data on rate versus rhythm control.
Results: Of 9,559 patients enrolled, 6,540 (68%) were managed with rate control versus 3,019 (32%) with rhythm control. Patients managed with rate control were significantly older and more likely to have hypertension, sleep apnea, heart failure, chronic lung disease, prior CVA, GI bleeds and less likely to be living independently. (Table) . Patients managed with rate control had lower EHRA symptom scores (ie, fewer symptoms), had slightly lower LVEF (54±12 vs 55± 12; p<.001), and larger left atrial diameters (4.8±0.9 vs 4.3±0.8 cm). Those managed with rhythm control were more likely to be treated by electrophysiologists and were less likely to have permanent AF. Anticoagulation was prescribed in 4,955 (76%) rate-controlled patients versus 1,915 (63%) rhythm-controlled patients (p<0.0001).
Conclusions:
In US clinical practice, patients with AF are more commonly managed with a rate control strategy. Patients selected for rhythm control were younger, had less comorbidity, had less permanent AF and were more likely treated by electrophysiologists.
Baseline characteristics of patients in the ORBIT-AF registry, stratified by AF management strategy. 
